Evidence map›Paper›PMID 27306990›Full record

ArticleCommunity mental health journal2016

Comorbid Moderate-Severe Depressive Symptoms and their Association with Quality of Life in Chinese Patients with Schizophrenia Treated in Primary Care.

Cai-Lan Hou, Xin-Rong Ma, Mei-Ying Cai, Yan Li, Yu Zang, Fu-Jun Jia, Yong-Qiang Lin, Helen F K Chiu, Gabor S Ungvari, Brian J Hall and 3 more

Abstract read
PubMed Publisher
In one paragraph

Article in Community mental health journal, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Cai-Lan HouGuangdong Mental Health Center, Guangdong General Hospital, Guangdong Academy of Medical Sciences, Guangzhou, Guangdong, China.
Xin-Rong MaNingxia Mental Health Center, Ningxia Ning-An Hospital, Yinchuan, Ningxia, China.
Mei-Ying CaiGuangzhou Yuexiu Center for Disease Control and Prevention, Guangzhou, Guangdong, China.
Yan LiMood Disorders Centre, Beijing Anding Hospital, Capital Medical University, Beijing, China.
Yu ZangShenzhen Key Laboratory for Psychological Healthcare, Shenzhen Institute of Mental Health, Shenzhen Kangning Hospital, Shenzhen Mental Health Center, Shenzhen, China.
Fu-Jun JiaGuangdong Mental Health Center, Guangdong General Hospital, Guangdong Academy of Medical Sciences, Guangzhou, Guangdong, China. jiafujun@126.com.
Yong-Qiang LinGuangdong Mental Health Center, Guangdong General Hospital, Guangdong Academy of Medical Sciences, Guangzhou, Guangdong, China.
Helen F K ChiuDepartment of Psychiatry, Chinese University of Hong Kong, Hong Kong SAR, China.
Gabor S UngvariSchool of Psychiatry and Clinical Neurosciences, University of Western Australia, Perth, Australia.
Brian J HallDepartment of Psychology, University of Macau, Macao SAR, China.
Bao-Liang ZhongDepartment of Psychiatry, Chinese University of Hong Kong, Hong Kong SAR, China.
Xiao-Lan CaoShenzhen Key Laboratory for Psychological Healthcare, Shenzhen Institute of Mental Health, Shenzhen Kangning Hospital, Shenzhen Mental Health Center, Shenzhen, China.
Yu-Tao XiangUnit of Psychiatry, Faculty of Health Sciences, University of Macau, Avenida da Universidade, 3/F, Building E12, Macau SAR, Taipa, China. xyutly@gmail.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This study described the prevalence and correlates of comorbid moderate-severe depressive symptoms (comorbid depression thereafter) and their association with quality of life (QOL) in schizophrenia patients treated in primary care. 623 schizophrenia patients were enrolled. Patients' socio-demographic and clinical characteristics including comorbid depression [defined as a total score of 18 or above on the Montgomery-Asberg Depression Rating Scale (MADRS)] were recorded. Depressive symptoms (defined as a total score of 9 or above on the MADRS) were present in 54.1 % of patients, while 17.7 % had comorbid depression. Analysis of covariance revealed that comorbid depression was significantly associated with lower mental QOL. Multiple logistic regression analysis revealed that more severe positive and negative symptoms, anxiety symptoms, use of first-generation antipsychotics and antidepressants, were independently associated with comorbid depression. Given the negative association between comorbid depression and QOL, attempts to address comorbid depression in schizophrenia patients treated in primary care should be made.

Indexed as

ComorbidityPrimary Health CareQuality of LifeAdultAntidepressive AgentsAntipsychotic AgentsAsian PeopleChinaCross-Sectional StudiesDepressive DisorderFemaleHumansMaleMiddle AgedSchizophreniaSurveys and QuestionnairesAntidepressive AgentsAntipsychotic AgentsChinaCommunity-dwellingDepressive symptomsPrimary careSchizophrenia

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.